Net sales dropped 30% year-over-year in Q2 and H1 2024, with significant losses driven by a weak healthcare staffing market, restructuring costs, and goodwill impairment. Cost-saving measures and new contracts aim to stabilize performance in H2.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.